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Abstract
Drosophila imaginal discs are epithelial tissues perfectly suited to use them as a playground 
to define the functional contribution of genes to epithelial development and organ morpho-
genesis. The more we know about the discs and the mechanisms directing their develop-
ment, the best prepared we are to assign specific “functions” to individual genes based on 
phenotypic observations. Conversely, and thinking from the perspective of the gene, the 
more we know about its function, the best inferences we could make about the mechanisms 
underlying imaginal disc development. This reciprocal relationship, coupled to the arsenal 
of possible experimental approaches available in Drosophila genetics, genomics and cel-
lular biology, makes these tissues excellent systems to address biological problems with 
biomedical relevance. In this review, an overview of three interconnected aspects related to 
the use of Drosophila imaginal discs as an experimental system to analyze gene function is 
given: (i) imaginal discs biology, with a focus in the genetic mechanisms involved in pattern 
formation; (ii) concepts and available experimental tools for the analyses of gene function 
and (iii) uses of Drosophila and the imaginal discs for addressing biomedical problems.
Keywords: Drosophila, genetic analysis, growth control, pattern formation,  
imaginal disc
1. Introduction
Imaginal discs are epithelial tissues that grow within the larva of holometabolous insects 
and differentiate most of the external parts of the adult during metamorphosis [1]. They are 
named after the adult structures they form, for example, the wing imaginal disc makes the 
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wing and the thorax, while the leg discs develop the leg appendages and the pleura. Each 
disc has a characteristic size, shape, histology and fate map, and they are connected to the 
larval epidermis and to the tracheal system of the larvae [1]. Imaginal discs are a favorite 
subject of study for developmental and cell biologists, and the analysis of their characteris-
tics has shaped key concepts in developmental biology, including the notions of cell deter-
mination, cell autonomy and positional information [2]. The study of imaginal discs is also 
contributing to identify and characterize the cellular and biochemical mechanisms underly-
ing these concepts.
A key peculiarity that in part account for the success of the imaginal discs as experimental 
model systems is that they retain a considerable developmental plasticity during larval 
development. Thus, when let unperturbed, each imaginal disc will undergo with a clock-
like precision cell divisions, growth and territorial specification, forming a fixed inventory 
of cuticular structures during differentiation. Simultaneously, the discs remain extremely 
plastic and reactive to experimental manipulations during most of their development. This 
developmental plasticity is particularly manifested when the discs are cut and transplanted 
into adult host, where disc fragments can reconstitute the missing parts (“regeneration”) 
and even alter their identity (“transdetermination”) [2, 3]. The ability to regenerate has 
been more recently observed in situ in experiments in which disc fragments are mechani-
cally removed or where particular regions are eliminated through the induction of cell 
death [3–5].
Imaginal discs are also extremely reactive to genetic manipulations, and altering the 
expression of genes encoding a wide variety of proteins related to epithelial development 
in imaginal cells results in precise adult phenotypes [6]. The responsive nature of imaginal 
discs to genetic and other experimental manipulations is one of the reasons explaining 
why imaginal discs have been repetitively used in developmental biology. In fact, they 
have traditionally been either drivers or early adopters of novel experimental approaches 
directed to unravel the genetic and cellular basis of epithelial biology and organ mor-
phogenesis [2]. In this manner, imaginal discs not only played a key role in the transition 
from experimental embryology to developmental genetics but also in the posterior move 
from formal mechanistic interpretations to increasingly detailed molecular and cellular 
descriptions.
Another aspect that explains the success of imaginal discs as experimental tools at different 
historical periods is the richness of biological processes participating in their development 
and differentiation. Thus, most common developmental operations, including cell prolifera-
tion and death, cell growth and differentiation, pattern formation and tissue mechanics and 
morphogenesis, as well as their underlying molecular mechanisms, can be analyzed in the 
discs. Because these processes are common to the development of all multicellular organ-
isms and also regulated by conserved genes and molecular interactions, the discs are a most 
convenient system to dissect genetically complex developmental mechanisms. In this review, 
some key aspects of imaginal disc biology are summarized, and the experimental tools avail-
able to analyze the contribution of genes to the development of imaginal disc development 
are described. We will also summarize how to capitalize on the knowledge we have about the 
discs to address problems with biomedical impact.
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2. Genetic regulation of imaginal disc development
Imaginal discs are versatile, responsive and modular tissues for genetic experimentation. 
Internal regulatory processes not only determine their development but they also commu-
nicate and interact with other larval organs to influence growth and developmental timing 
[7–10]. In the discs, patterning and growth are interconnected aspects driven by conserved 
signaling pathways and complex transcriptional regulatory networks that coordinate gene 
expression along a field of epithelial cells. Although each imaginal disc has its own pecu-
liarities, their modes of development share multiple common aspects, including regulated cell 
proliferation and the progressive generation of gene expression domains. Thus, a common fea-
ture of all discs is the existence of a continuous deployment and refinement of gene expression 
patterns that culminate in the allocation of cellular fates to individual cells or fields of cells. 
This process is linked to the position that each cell occupies in the epithelium, but it is mostly 
a consequence of each cell developmental history, as defined by the gene regulatory networks 
that were operating in its progenitors. The mechanistic links between gene activity and the 
patterned distribution of differentiated cells make possible to use phenotypic approaches to 
identify and characterize the function of individual genes through genetic analysis.
The origin of imaginal cells is the embryonic ectoderm. It is in this epithelial layer where 
a set of gene regulatory events defines the position of groups of cells as imaginal precur-
sors [1, 11] (Figure 1). The specification of each imaginal primordium follows the same logic 
of gene regulatory events that will direct their subsequent development. Thus, the seg-
mented embryonic ectoderm contains a Cartesian system of positional information along the 
antero-posterior (A/P) and dorso-ventral (D/V) axes defined by the expression of ligands 
Figure 1. Specification of the thoracic appendage primordia. (A) Schematic representation of Drosophila embryogenesis 
indicating the position of the primordia for the thoracic discs in the T1, T2 and T3 segments. (B) Development of the disc 
primordium in the T2 segment. At stage 11, Dll expression (dark grey circle) is activated by Wg and repressed dorsally 
and ventrally by the Dpp and EGFR pathways, respectively. Some hours later, the wing primordium marked by the 
expression of vg and sna originates (light grey circle) and includes both Dll-expressing cells and Dll non-expressing cells. 
At stage 14, the wing and leg primordia are fully separated. The genetic inputs into Dll and sna/vg are schematized. Note 
that these genes integrate differentially the activity of the Wg, Dpp and EGFR pathways.
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belonging to the Hedgehog (Hh), wingless (Wg), decapentaplegic (Dpp) and epidermal 
growth factor receptor (EGFR) pathways [1, 12–15] (Figure 1). The restricted expression of 
these ligands results in the generation of overlapping signaling domains in which pathway-
specific transcription factors are expressed or active (Figure 1). These transcription factors act 
through cis-regulatory modules (CRM) present in a set of genes involved in the early determi-
nation of embryonic cells as imaginal precursors. Some of the best-characterized genes belong-
ing to this class are eyeless (eye), vestigial (vg), Distal-less (Dll), escargot (esg), buttonhead (btd) and 
Sp1 [11, 16–19]. The expression of these genes becomes restricted to groups of cells positioned 
with respect to parasegmental boundaries and located in precise A/P and D/V positions [20].
Complementary to the A/P and D/V coordinate systems, which are common to all embryonic 
segments, the ectoderm also bears a segment-specific code of homeotic genes resulting from 
the differential expression of the Bithorax (Bx) and Antennapedia (Antp) gene complexes [21]. 
The genes of the Bx complex prevent the development of imaginal primordia from the abdomi-
nal segments and confer different identities to the thoracic segments 2 and 3. Similarly, the 
genes of the Antp complex confer segmental identity to the imaginal precursors present in 
the cephalic segments [21]. Once the position, size and identity of each primordium are deter-
mined, its development implies cell proliferation and invagination from the embryonic surface 
[1]. For all subsequent stages, the discs will grow as hollow sacs within the interior of the larvae 
that remain connected through a stalk to the larval epidermis. From the primordia that were 
specified in the embryo to the mature third instar discs, there happens a considerable increase 
in size due to cell proliferation, and this increase is always accompanied by the generation of 
gene expression domains that progressively become coincident with the adult structures; each 
cell will give rise during metamorphosis (Figure 1). The same signaling pathways that partici-
pate in the specification of the primordia drive the generation of gene expression domains. The 
continuous interplay between signaling and transcription is a common aspect to the develop-
ment of all discs. In this manner, at each time-point in the development of the discs, localized 
domains of signaling are converted into territories of gene expression, which in turn drive the 
generation of novel signaling domains directing further domains of gene expression (Figure 2).
The examples of the leg and wing discs illustrate how signaling-transcription networks cou-
pled to the increase in the size of the epithelium have been adapted to generate diverse expres-
sion patterns associated to cell fate allocations. The leg and wing discs originate from the same 
primordium located in the ventral region of each hemisegment of the mesothorax (paraseg-
ment 5). These early primordia can first be recognized as a group of ~30 cells in each thoracic 
hemisegment that express the homeobox gene Dll [22]. Dll expression is activated by Wg and 
repressed dorsally and ventrally by the Dpp and EGFR pathways, respectively [23]. These Dll-
expressing cells give rise to all regions of the adult thorax, including both the ventral (i.e., legs) 
and dorsal (i.e., wing and haltere) appendages [22, 24]. As the embryo develops, a group of 
cells of these early primordia moves dorsally to form the dorsal primordia (wing and haltere), 
lose Dll expression and activate the wing-promoting genes, vestigial (vg) and snail (sna) [16, 22, 
25] (Figure 1). The remaining Dll-expressing cells in each thoracic hemisegment give rise to 
the leg discs [24, 26] (Figure 1). At the molecular level, the signals that govern the separation 
between the dorsal and ventral primordia are integrated by the CRMs of the Dll and sna genes. 
Dpp is required for the expression of Dll and sna, whereas Wnt and EGFR signalling repress 
wing fate and promote leg primordia formation [14, 15].
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From this point onwards, both groups of cells follow their development independently, using 
the information already present in the primordium to drive subsequent developmental steps. In 
the case of the wing disc, the first subdivision imposed over the antero-posterior compartment 
initial subdivision is between proximal and distal cells (Figure 2). Proximal cells express the 
EGFR ligand vein (Vn), whereas distal cells express the gene wingless (wg) [15, 27, 28]. Decreasing 
EGFR signalling levels from distal to proximal regions of the disc regulates the formation of 
nested expression domains of genes encoding transcription factors. In more proximal cells, 
the genes of the Iroquois (Iro) and Spalt (sal) complexes are expressed and contributed to the 
determination of the future thorax [27, 29–31]. In a more extended domain, the expression of 
apterous (ap) is also activated in response to the EGFR pathway [15, 32, 33], and the Notch sig-
naling pathway is activated at the boundary between cells expressing and not expressing ap 
and drives the expression of vestigial (vg), a cofactor necessary for the specification of wing cells 
[25, 34–38]. From now onwards, the territories fated to become the thorax, hinge and blade will 
expand and further divide into smaller subdomains of gene expression related to pattern ele-
ments such as veins and sensory organs (Figure 2). In the expanding wing blade, for example, 
Figure 2. Overview of leg and wing imaginal disc patterning. (A) Schematic representation of the leg disc at different 
developmental stages, from early L2 (left) to late L3 (right). Initially, Wg (dark grey) and Dpp (light grey) activate Dll 
expression in the distal domain of the leg (grey circle) and repress dac. As the disc grows, dac expression (striped and grey 
circle) escapes the repression of Wg and Dpp, and the initial PD axis is established. Later on, the distal part of the leg is 
further subdivided in nested expression patterns by the activity of the EGFR pathway, which ligand is expressed in the 
distal-most tip of the leg disc. The combinatorial code of the PD axis patterning genes localized the activation of the Notch 
pathway (circles) in concentric rings that prefigure the joints of the adult leg. (B) Schematic representation of the wing disc 
at different developmental stages, from L2 (left) to late L3 (right). The L2 disc is subdivided into a proximal domain where 
the EGFR pathway is active (dark grey) and an anterior distal domain where the Wg pathway is active (light grey)—EGFR 
signaling activates the expression of the Iroquois genes (Iro) and apterous (ap). The confrontation of ap expressing and 
not expressing cells triggers Notch activation and vestigial (vg) expression in the primordium of the wing blade. Proximal 
cells express the homothorax gene (hth; stripped) and will contribute to the hinge region of the wing. The wing blade 
is subdivided into expression domains due to the activity of the Hedgehog and Decapentaplegic signaling pathways. 
The expression of optix (black), spalt (sal; light grey) and knot (dark grey) is shown. The expression of Knirps (kni) and 
Iroquois (Iro) is then activated in provein territories (lines) from where later each longitudinal vein (L2-L5) differentiates.
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most of the expression territories are established with respect to the A/P compartment boundary 
due to the activity of the Hh and Dpp signaling pathways [39]. In this manner, the central 
region of the wing is patterned by the differential response to Hh signaling of a battery of genes 
required for the positioning of the central wing veins (L3 and L4) and the central intervein (L3/4 
intervein) [40]. Simultaneously, the lateral regions of the wing blade are patterned through a set 
of transcription factors which expression is regulated by the Dpp signaling pathway (Figure 2).
In the case of the leg, the restricted expression of Dpp and Wg in dorsal and ventral domains 
of the leg imaginal disc directs the formation of the proximo-distal (P/D) axis. Initially, high 
levels of Wg and Dpp activate Dll in the center of the leg disc and repress the expression of 
dachshund (dac). As the discs grow, dac escapes the repression of Wg and Dpp in the medial 
domain of the leg disc and is activated by Dll [23]. Once these genes are activated, their expres-
sion is locked by autoregulatory mechanisms. In the periphery of the disc, where combined 
low levels of Wg and Dpp are found, the expression of homothorax (Hth) and teashirt (Tsh) is 
activated. Later on, the activity of the EGFR pathway in the distal domain of the leg disc is 
required to activate a series of secondary P/D targets, including the tarsal restricted genes 
aristalless (al), Bar (B) and rotound (rn) [11, 23] (Figure 2). An important consequence of the P/D 
subdivision is the activation of the Notch pathway in concentric rings that subsequently cor-
respond to the joints, movable structures separating adjacent leg segments [41]. Joint devel-
opment is controlled by the action of subsidiary Notch target genes, such as the transcription 
factors encoded by oddskipped family genes (odd) and dysfusion (dys) in proximal and distal 
joints, respectively. In particular, Dys regulates the expression of several Rho-GTPase regula-
tors and pro-apoptotic genes that together sculpt the tarsal joints [42, 43].
In summary, as the discs grow in size, its pattern is progressively established and prefigurates 
as expression domains the position where different structures, such as veins, sensory organs 
and tarsal joints, that will differentiate during metamorphosis. This process relies upon reg-
ulatory mechanisms that link signaling with transcriptional regulation along the epithelium. 
Subsequently, each disc will initiate its differentiation and morphogenesis during pupal devel-
opment, in a course that includes extensive morphogenetic movements and fusion between ima-
ginal discs. The culmination of imaginal disc development is the generation of precise patterns 
of differentiation. As these patterns are under strict regulation of genes encoding transcription 
factors and signaling components, changes in the expression pattern or activity of these genes 
result in precise alterations of the pattern of cell differentiation and organ morphogenesis. These 
alterations, the mutant phenotypes, can be used as diagnostic criteria to define the requirements 
of the gene and to annotate its function in relation to the processes affected. Most of the impact 
of Drosophila in biological research is due to the availability of methods to analyze gene func-
tion in vivo. These methods rely on the power to generate and analyze mutations and to detect 
the timing and patterning of gene expression. It is through the analysis of the consequences of 
manipulating gene activity that specific functions could be assigned to particular genes.
3. Genetic analysis in Drosophila
When genetic analysis was first used to characterize the contribution of a gene to a particular 
process, the definition of “gene function” was abstract, referring more to the requirement of the 
gene than to the actual biochemical function of the protein it encoded, which was for the most 
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part unknown. Thus, genes encoding transcription factors or signaling molecules could be clas-
sified as “segmentation genes,” because they displayed mutant phenotypes affecting the seg-
mentation of the embryo [44]. By looking at the particularities of the mutant phenotype, these 
genes could be further classified into discrete classes that later were shown to correspond to the 
different levels in the hierarchy of regulatory interactions driving segmentation [44]. During 
most of the 20th century, methods to analyze a gene were blind to a large extent. In this manner, 
mutations generated randomly were selected because they failed to complement a particular 
allele or gene deficiency [45, 46] or because they displayed or modified a phenotype in the tis-
sue of interest [47–50]. Favorite methods to generate mutations were chemical (EMS), physical 
(ionizing radiations) and later through the mobilization of transposable elements [51, 52].
The availability of the Drosophila DNA sequence in 2000 [53], combined with the develop-
ment of novel techniques to generate mutations in the following years, marked a shift in the 
way genes were studied. When the entire genetic map of the fly was open to scrutinize, it 
was necessary to develop new methods that allowed the generation of gene-specific muta-
tions from the sequence (“reverse genetics”). In this manner, homologous recombination was 
adopted to fly genetics [54, 55], although the technical complexity and low frequency of these 
events precluded a generalized adoption by the fly community. More impact had the imple-
mentation of RNA interference (RNAi), which combined with the Gal4/UAS system, already 
extensively used to generate gain-of-function conditions [56] allowed a targeted reduction of 
mRNA levels of the gene of interest in specific tissues [57]. The generation of genome-wide 
collections of UAS-RNAi lines further allowed screening systematically the genome, either 
by searching for mutant phenotypes in the tissue of interest or for modifiers of a particular 
genetic condition [58, 59]. RNAi is being massively used as a first approach to identify the 
functional requirements of a gene or gene family of interest, but still has the problems of 
generating only hypomorphic conditions and the existence of off-target effects caused by 
sequence similarities.
In more recent years, the adaptation of the CRISPR/Cas9 technology to the fly is allowing an 
unprecedented level of precision and easiness with which a gene can be targeted [60–63]. This 
method is based on the use of the nuclease Cas9 guided by small RNAs (gRNAs) to generate 
double-strand breaks (DSB) at a target genomic locus, allowing its use as a highly efficient 
and specific system for gene edition. Using CRISPR/Cas9 allows targeted manipulation of a 
given gene in different manners. Thus, the CRISPR/Cas 9 system can be employed to generate 
sequence-specific DSB to disrupt the target locus when a single gRNA is used, resulting in the 
generation of small insertion or deletions (In/Dels) through the error-prone process of non-
homologous end-joining (NHEJ) repair in the coding sequence. This approach can be used to 
disrupt coding genes, leading to an array of mutations ranging from hypomorphs to amorph 
alleles (Figure 3), caused by frameshifts in the reading frame, premature stop codons or triplet 
insertions or deletions [63–65]. The NHEJ repair system can also be directed by two gRNAs to 
delete a specific fragment flanking the targeted sequences [63, 66]. The resulting DNA change 
consists in a deletion of a longer sequence, which could include an entire open reading frame, 
an exon or also non-coding sequences such as candidate regulatory regions, being also an 
useful approach to analyze transcriptional regulation in situ (Figure 3).
A second application of the CRISPR-Cas9 system is to stimulate HDR (homology-direct repair) by 
using homologous DNA sequences as template for the DNA repair and two gRNAs, allowing precise 
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genome editing by generating sequence substitutions following a deletion (knock-out/knock-in). 
This method relies on supplying a homologous repair DNA (ssDNA or dsDNA) engineered with 
the desired modifications [62, 67–69]. This approach allows not only the induction of particular 
mutations in the genome but also the integration of ssDNA oligonucleotides for epitope TAGs 
into protein coding genes, allowing the tagging of endogenous proteins (Figure 3).
More interestingly, when stimulating HDR using longer homologous repair dsDNA (homol-
ogy arms), the removed genomic region can be replaced with site-specific recombinase 
sequences such as attP sites [67], allowing subsequent integrations at this genomic position 
of modified versions of the gene or orthologous genes and sequences encoding for tagged 
proteins (Figure 3). Creation of a DSB dramatically increases the frequency of homologous 
recombination [70], allowing the expression in situ of protein variants expressed under the 
same regulatory DNA as the endogenous gene (Figure 3). In addition, Flippase recognition 
target (FRT) sites could be introduced flanking the region on interest to allow tissue-specific 
Figure 3. Applications of CRISPR/Cas9 for gene editing in Drosophila. Schematic representation of Cas9-DNA interactions 
leading to changes in the genomic sequence (A–C) or to changes in gene expression (D). The genomic DNA is represented 
as thick lines, Cas9 is represented by a grey shape, guide RNA (gRNA) are shown as grey lines and nucleotides targeted 
by gRNA as grey ovals. (A) Single gRNA leads to DNA double strand breaks (left) that are corrected by non-homologous 
end joining (right) leading to INDELs. (B) Double gRNAs lead to nearby double strand breaks (left) that when corrected 
result in a deletion of the DNA located between adjacent breaks (right). (C) The use of two gRNAs in the presence of 
sequences with homology to the target DNA (left) leads to the substitution of this DNA (knock-out) by the selected 
sequence (knock-in), in this case a tagged version of a coding region (Flag). (D) The targeting of inactive forms of Cas9 
(nuclease-null Cas9) fused with activating (left) or repressor (right) domains leads to the corresponding changes in gene 
expression from adjacent promoters.
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or clonal deletion of specific sequences [67] (Figure 3). Engineered alleles can be subsequently 
interrogated by their impact on any particular part of the fly or used to follow the expression 
of the protein of interest due to the incorporation of different TAGs (Figure 3).
Beyond genome engineering, CRISPR/Cas9 has also been used to regulate endogenous gene 
expression in both cells and organisms without causing any mutation. For this approach, a nucle-
ase-dead or inactive Cas9 is fused to a transcriptional activator or repressor domain and can be 
recruited to specific target DNA by its gRNAs, allowing activation through CRISPR or repres-
sion by CRISPR interference (Figure 3) [71–73]. In addition, an inactive Cas9 co-expressed with 
a gRNA can also be used for immunoprecipitation of specific DNA regions as a variant form of 
engineered DNA binding-mediated chromatin immunoprecipitation (enChIP), and associated 
proteins can be subsequently identified by mass spectrometry (enChIP-MS) [74]. In summary, 
CRISPR/Cas9 technology is providing a precise and efficient method for sequence-specific target-
ing of Cas9, resulting in genomic alterations, changes in gene expression and even the isolation of 
protein complexes bound to specific DNA regions. The application of this technology is trigger-
ing an unprecedented level of precision in genetic and genomic analysis in Drosophila research.
4. Uses of Drosophila and the imaginal discs to address biomedical 
problems
The precision by which the genome can be modified, combined with the knowledge we have 
about the cellular and molecular fundaments of imaginal disc development, justify the use 
of these epithelial tissues as experimental models to address a variety of biological questions, 
including biomedical ones. According to the Homophila database, around 75% of human disease 
genes cataloged in OMIM (On-line Mendelian Inheritance in Man) database have close homologs 
in the fruit fly [75]. This high degree of evolutionary conservation makes even more compelling 
the use of Drosophila melanogaster to develop experimental models of human diseases [76, 77].
The generation of Drosophila models for human diseases includes a variety of approaches, 
including blind and unbiased large-scale genetic screens, functional analysis of Drosophila genes 
orthologous for a known human disease gene, the expression of human genes in Drosophila 
tissues and the construction of genetic models that reproduce some characteristics of complex 
human syndromes such as cancer, kidney and metabolic diseases among many others [78–86]. 
These approaches are focused on either the gene or genes causing the disease or, complemen-
tary, the tissue where the disease is manifested. A successful example of the first approach, 
unbiased genetic screens, involved a mosaic screen of newly generated lethal mutations in 
the X chromosome that allowed the identification of 21 novel genes associated with human 
diseases for which no mutations were previously known [87]. The analysis of Drosophila genes 
with human counterparts contributing to human diseases has been mostly applied in the con-
text of several neurodegenerative diseases, and some examples are the analysis of parkin and 
Pink1, genes related to Parkinson disease, and sphingosine-1-P-lyase for Charcôt-Marie-Tooth 
neuropathy [88]. In these cases, the Drosophila model allows a first approximation to study 
the functional relevance of the gene, including the consequences of its loss, its expression, 
the subcellular localization of the protein and its biochemical characteristics. Similarly, the 
expression of human proteins in flies has mostly targeted neurodegenerative diseases such 
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as Alzheimer disease, Tau-induced neurodegeneration (Tauopathy), polyglutamine diseases 
including Huntington disease and spinocerebellar ataxia, among others [89]. In this manner, it 
was shown that the overexpression of the human Aβ42 protein in the central nervous system 
of Drosophila causes amyloid deposition, progressive learning defects, extensive neurodegen-
eration and shortened lifespan, all of the hallmarks of Alzheimer’s disease [90].
Apart from offering a convenient experimental system to identify the function of a gene or 
the consequences of the expression of relevant protein variants, Drosophila has been instru-
mental in expanding the catalog of relevant genes contributing to the function and outcome 
of a particular genetic condition through the use of “genetic modifier screens”. These experi-
ments consist in the search for mutations that can either increase or suppress the phenotype 
caused by a genetic condition of interest, under the assumption that these modifying alleles 
might identify additional components relevant for the function of the protein of interest. 
Such approach has been applied to a variety of genetic backgrounds, either in blind genetic 
screens, i.e., through the generation of random mutations in a particular genetic background, 
or by introducing in these backgrounds the expression of RNAi directed against all genes or 
particular candidates. Using these approaches, it was found that mutations in Neprilysin 2 
modify the progressive retinal degeneration concomitant with plaque formation caused by 
the overexpression of human Aβ42 in the Drosophila eye [91].
Drosophila can also be effectively used for drug screens as well as in target discovery [77, 92]. 
Screening for novel drugs in flies enables for the selection of candidates with physiological 
characteristics that are difficult to analyze by cell culture or biochemical assays. In addition to 
high-throughput screening of potential therapeutics, Drosophila is a powerful tool for studying 
the molecular mechanism of a specific drug in vivo. The diminished effort and costs of analyz-
ing the targets and possible “off-targets” in a Drosophila model make it useful as a first valida-
tion organism for establishing the efficacy and toxicity of a drug in vivo. In fact, some approved 
treatments, such as the kinase inhibitor vandetanib (ZD6474) for treating medullary thyroid 
carcinoma patients, were validated in Drosophila previous to clinical trials [93]. When using 
Drosophila for developing a treatment, it is important to consider the possible differences in 
pharmacokinetics of a drug in this organism and the differences in tissular distribution, which 
may affect the optimal doses of the compound. Also toxicity might be different, although a 
strong correlation has been shown [94]. Nowadays, there are several companies that have been 
using Drosophila melanogaster as human disease model for screening for therapeutic drugs such 
as Aktogen, En Vivo Pharmaceuticals, Genescient Corp and Medros Pharmaceuticals. Indeed, 
the ease of screening big samples of individuals has also been employed for drug discovery in 
Drosophila disease models. For example, a library of 2000 compounds was checked in a Fragile-X 
syndrome Drosophila model for pharmacological rescue [95], and 9 molecules were found to 
rescue lethality, among them three belonging to GABAergic inhibitory pathway. This and fur-
ther studies led to the performance of human trials of GABAergic treatment (reviewed in [96]).
5. Conclusions
Several characteristics converge to sustain and reinforce the use of Drosophila in the post-
genomic era as a motor for biomedical research. The availability of novel techniques to 
manipulate and scrutinize the genome with unprecedented sophistication and precision can 
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be used in experimental models, such as the imaginal discs, that are particularly well suited 
for genetic and molecular analyses. The convergence of technical improvements used in a 
favorable experimental system is sustained by the functional conservation of the relevant 
genes and the cellular processes they regulate and by the multiple adaptations that this 
system allows, including genetic, biochemical, cellular and pharmacological experimental 
approaches.
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